eli lilly's dtc obesity drug push 'not necessarily an industry game changer': mizuho's jared holz
Published 7 months ago • 4.1K plays • Length 6:08Download video MP4
Download video MP3
Similar videos
-
7:35
eli lilly's zepbound single-dose vials will expand access to more patients: mizuho's jared holz
-
5:47
zealand's obesity drug shouldn't disrupt novo nordisk-eli lilly leadership: mizuho's jared holz
-
3:53
eli lilly's alzheimer drug is 'a nice additional therapy', says mizuho's jared holz
-
5:53
eli lilly and novo nordisk will remain leaders in the weight-loss drug market: mizuho's jared holz
-
5:33
eli lilly ceo david ricks on 3-year obesity drug study: this is a profound result
-
4:04
eil lilly announces zepbound to be sold directly to consumers
-
2:51
evercore's emanuel sticks with 6,000 s&p 500 forecast
-
6:48
eli lilly's alzheimer's drug slowed cognitive decline in phase 3 study
-
6:43
eli lilly ceo on weight loss drugs outlook: our top priority is making more product
-
1:46
eli lilly releases new form of weight loss drug zepbound for half the price to boost access, supply
-
6:00
eli lilly's zepbound may be best-in-breed for weight loss drugs, says dr. kavita patel
-
4:57
health care bucks sell-off as eli lilly soars: mizuho's jared holz on what's next for the group
-
4:25
people are 'scratching and clawing' for negative narrative around obesity drugs: mizuho's jared holz
-
3:40
eli lilly's obesity drug will be a tailwind for the stock, says bmo's evan seigerman
-
0:55
eli lilly ceo on compounded versions of weight loss drugs
-
1:32
eli lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
-
5:24
eli lilly goes direct-to-consumer on weight loss drugs: what patients and investors need to know
-
2:56
eli lilly to offer weight loss drug directly to qualifying customers at lower price
-
0:59
eli lilly ceo on why food companies haven't seen a big impact on sales
-
4:08
weight loss drug market is just beginning to take off, says mizuho's jared holz
-
3:23
potential for weight-loss drugs boosts eli lilly
-
3:52
novo and eli lilly stocks could go higher if they show even better data than we think: mizuho's holz